BridgeBio Pharma Inc. (BBIO) Announces Commercial Progress, Program Updates, and 2025 Milestones
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
| (NASDAQ: BBIO) | Delayed: 65.35 +0.31 (0.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.04 | 52 Week High | $ | |||
| Open | $65.04 | 52 Week Low | $ | |||
| Day High | $65.94 | P/E | N/A | |||
| Day Low | $64.34 | EPS | $ | |||
| Volume | 1,846,509 | |||||
